[1]
|
B. Blattberg, “Increase in Bactericidal Activity as A Result of Injection of Zymosan,” Proceedings of the Society for Experimental Biology and Medicine, Vol. 92, No. 4, 1956, pp. 745-748.
|
[2]
|
G. C. Chan, W. K. Chan and D. M. Sze, “The Effects of Beta-Glucan on Human Immune and Cancer Cells,” Journal of Hematology & Oncology, Vol. 2, No. 2009, 2009, p. 25.
|
[3]
|
D. B. Zekovic, S. Kwiatkowski, M. M. Vrvic, D. Jakovljevic and C. A. Moran, “Natural and Modified (1 3)-Beta-D-Glucans in Health Promotion and Disease Alleviation,” Critical Reviews in Biotechnology, Vol. 25, No. 4, 2005, pp. 205-230.
doi:10.1080/07388550500376166
|
[4]
|
L. G. Fleischer, G. Gerber, G. Gremmels, H.-D. Lippert and G. Westphal, “Experimentelle Modelluntersuchungen zum Einsatz von (1,3),(1,6)-Beta-D-Glucan aus Saccharomyces Cerevisiae Fibona Health Products GmbH,” 2001.
|
[5]
|
J. Li, J. Xing, D. Li, X. Wang, L. Zhao, S. Lv and D. Huang, “Effects of Beta-Glucan Extracted from Saccharomyces Cerevisiae on Humoral and Cellular Immunity in Weaned Piglets,” Archives of Animal Nutrition, Vol. 59, No. 5, 2005, pp. 303-312.
doi:10.1080/17450390500247832
|
[6]
|
D. Akramiene, A. Kondrotas, J. Didziapetriene and E. Kevelaitis, “Effects of Beta-Glucans on the Immune System,” Medicina, Vol. 43, No. 8, 2007, pp. 597-606.
|
[7]
|
J. A. Bohn and J. N. BeMiller, “(1→3)-β-D-Glucans as Biological Response Modifiers: A Review of Structure-Functional Activity Relationships,” Carbohydrate Polymers, Vol. 28, 1995, pp. 3-14.
doi:10.1016/0144-8617(95)00076-3
|
[8]
|
T. Kojima, K. Tabata, W. Itoh and T. Yanaki, “Molecular Weight Dependence of the Antitumor Activity of Schizophyllan,” Agricultural Biology and Chemistry, Vol. 50, No. 1, 1986, pp. 231-232. doi:10.1271/bbb1961.50.231
|
[9]
|
E. Sonck, B. Devriendt, B. Goddeeris and E. Cox, “Varying Effects of Different Beta-Glucans on the Maturation of Porcine Monocyte-Derived Dendritic Cells,” Clinical and Vaccine Immunology, Vol. 18, No. 9, 2011, pp. 14411446. doi:10.1128/CVI.00080-11
|
[10]
|
D. C. Nieman, D. A. Henson, M. McMahon, J. L. Wrieden, J. M. Davis, E. A. Murphy, S. J. Gross, L. S. McAnulty and C. L. Dumke, “Beta-glucan, Immune Function, and Upper Respiratory Tract Infections in Athletes,” Medicine and Science in Sports and Exercise, Vol. 40, No. 8, 2008, pp. 1463-1471.
doi:10.1249/MSS.0b013e31817057c2
|
[11]
|
J. Malaczewska, R. Wójcik, L. Jung and A. K. Siwicki, “Effect of Biolex β-HP on Selected Parameters of Specific and Non-Specific Humoral and Cellular Immunity in Rats,” Bulletin of the Veterinary Institute in Pulawy, Vol. 54, No. 1, 2010, pp. 75-80.
|
[12]
|
R. Wojcik, “Effect of Biolex Beta-HP on Phagocytic Activity and Oxidative Metabolism of Peripheral Blood Granulocytes and Monocytes in Rats Intoxicated by Cyclophosphamide,” Polish Journal of Veterinary Sciences, Vol. 13, No. 1, 2010, pp. 181-188.
|
[13]
|
R. Wójcik, E. Janowska, J. Malaczewska and A. K. Siwicki, “Effect of β-1,3/1,6-D-glucan on the Phagocytic Activity and Oxidative Metabolism of Peripheral Blood Granulocytes and Monocytes in Rats,” Bulletin of the Veterinary Institute in Pulawy, Vol. 53, No. 2, 2009, pp. 241-246.
|
[14]
|
R. Eccles, “Understanding the Symptoms of the Common Cold and Influenza,” Lancet Infectious Diseases, Vol. 5, No. 11, 2005, pp. 718-725.
doi:10.1016/S1473-3099(05)70270-X
|
[15]
|
S. Talbott and J. Talbott, “Effect of BETA 1,3/1,6 GLUCAN on Upper Respiratory Tract Infection Symptoms and Mood State in Marathon Athlets,” Journal of Sports Science and Medicine, Vol. 8, 2009, pp. 509-515.
|
[16]
|
D. C. Nieman, “Risk of Upper Respiratory Tract Infection in Athletes: An Epidemiologic and Immunologic Perspective,” Journal of Athletic Training, Vol. 32, No. 4, 1997, pp. 344-349.
|
[17]
|
N. P. Walsh, M. Gleeson, R. J. Shephard, J. A. Woods, N. C. Bishop, M. Fleshner, C. Green, B. K. Pedersen, L. Hoffman-Goetz, C. J. Rogers, H. Northoff, A. Abbasi and P. Simon, “Position Statement. Part One: Immune Function and Exercise,” Exercise Immunology Review, Vol. 17, 2011, pp. 6-63.
|
[18]
|
K. Bergendiova, E. Tibenska and J. Majtan, “Pleuran (Beta-Glucan from Pleurotus ostreatus) Supplementation, Cellular Immune Response and Respiratory Tract Infections in Athletes,” European Journal of Applied Physiology, Vol. 111, No. 9, 2011, pp. 2033-2040.
doi:10.1007/s00421-011-1837-z
|
[19]
|
S. Feldman, H. I. Schwartz, D. S. Kalman, A. Mayers, H. M. Kohrman, R. Clemens and D. Krieger, “Randomized Phase II Clinical Trials of Wellmune WGP for Immune Support during Cold and Flu Season,” Journal of Applied Research, Vol. 9, No. 1-2, 2009, pp. 30-42.
|
[20]
|
P. J. Rice, E. L. Adams, T. Ozment-Skelton, A. J. Gonzalez, M. P. Goldman, B. E. Lockhart, L. A. Barker, K. F. Breuel, W. K. Deponti, J. H. Kalbfleisch, H. E. Ensley, G. D. Brown, S. Gordon and D. L. Williams, “Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious Challenge,” Journal of Pharmacology and Experimental Therapeutics, Vol. 314, No. 3, 2005, pp. 1079-1086.
doi:10.1124/jpet.105.085415
|
[21]
|
H. S. Goodridge, C. N. Reyes, C. A. Becker, T. R. Katsumoto, J. Ma, A. J. Wolf, N. Bose, A. S. Chan, A. S. Magee, M. E. Danielson, A. Weiss, J. P. Vasilakos and D. M. Underhill, “Activation of the Innate Immune Receptor Dectin-1 upon Formation of a ‘Phagocytic Synapse’,” Nature, Vol. 472, No. 7344, 2011, pp. 471-475.
doi:10.1038/nature10071
|
[22]
|
R. Schoop, P. Klein, A. Suter and S. L. Johnston, “Echinacea in the Prevention of Induced Rhinovirus Colds: A Meta-Analysis,” Clinical Therapeutics, Vol. 28, No. 2, 2006, pp. 174-183. doi:10.1016/j.clinthera.2006.02.001
|
[23]
|
S. A. Shah, S. Sander, C. M. White, M. Rinaldi and C. I. Coleman, “Evaluation of Echinacea for the Prevention and Treatment of the Common Cold: A Meta-Analysis,” Lancet Infectious Diseases, Vol. 7, No. 7, 2007, pp. 473480. doi:10.1016/S1473-3099(07)70160-3
|
[24]
|
D. S. Senchina, N. B. Shah, D. M. Doty, C. R. Sanderson and J. E. Hallam, “Herbal Supplements and Athlete Immune Function—What’s Proven, Disproven, and Unproven?” Exercise Immunology Review, Vol. 15, 2009, pp. 66-106.
|
[25]
|
D. Sch?neberger, “Immunstimulierende Wirkung von Echinacin Madaus Liquidum auf Verlauf und Schweregrad von Erk?ltungskrankheiten,” Forum Immunologie, Vol. 8, 1996, pp. 2-11.
|
[26]
|
W. Grimm and H. Müller, “A Randomized Controlled Trial of the Effect of Fluid Extract of Echinacea Purpureaz on the Indicence and Severity of Colds and Respiratory Infections,” American Journal of Medicine, Vol. 109, 1999, pp. 138-143.
doi:10.1016/S0002-9343(98)00406-9
|
[27]
|
R. M. Douglas, H. Hemila, E. Chalker and B. Treacy, “Vitamin C for Preventing and Treating the Common Cold,” Cochrane Database of Systematic Reviews, Vol. 3, 2007, Article ID: CD000980.
|
[28]
|
M. Singh and R. R. Das, “Zinc for the Common Cold,” Cochrane Database of Systematic Reviews, Vol. 2, 2011, Article ID: CD001364.
doi:10.1002/14651858.CD001364.pub3
|